内镜手术与机器人辅助根治性前列腺切除术后阿片类药物使用及患者疼痛控制满意度
前瞻性队列研究在学术医疗中心纳入接受内镜泌尿外科手术和机器人辅助根治性前列腺切除术(RARP)的患者,通过电话问卷和病历回顾评估阿片类药物处方、使用及患者报告结局。内镜手术患者中多数未使用阿片类药物且疼痛控制良好、满意度高;RARP患者即使被处方阿片类药物也多数未使用,且疼痛控制满意。
要点
- 内镜手术患者中21%被处方阿片类药物,仅9%报告使用;87%对疼痛控制满意或非常满意。
- RARP患者中93%被处方阿片类药物,但仅23例报告使用;几乎全部患者疼痛控制良好或非常好。
- 多数患者术后未使用阿片类药物,且疼痛控制结局良好。
核心结论
- 大多数接受内镜泌尿外科手术的患者术后不使用阿片类药物,且疼痛控制结局良好。
- RARP术后大多数患者即使被处方阿片类药物也不使用,且对疼痛控制满意。
研究设计与样本
- 前瞻性队列研究,在学术医疗中心进行,包括患者电话问卷和病历回顾。
- 记录阿片类药物处方、阿片类药物使用及患者报告结局。
- 对内镜手术组报告总体趋势;对RARP组采用双变量分析比较使用与未使用阿片类药物的患者。
主要发现
- 68例接受内镜干预的患者中,14例(21%)被处方阿片类药物,6例(9%)报告任何阿片类药物使用。
- 内镜手术组中58例(85%)报告疼痛控制非常好或好,9例报告疼痛控制差;59例(87%)对疼痛控制满意或非常满意。
- 57例接受RARP的患者中,53例(93%)收到阿片类药物处方,仅23例报告任何阿片类药物使用。
- RARP组除1例外所有患者报告疼痛控制好或非常好,几乎全部(54例)对疼痛控制水平满意;36例(63%)报告疼痛低于预期,仅7例(12%)报告疼痛高于预期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate patient reported measures in patients undergoing endourologic procedures and robotic assisted radical prostatectomy (RARP) to demonstrate the efficacy of non-opioid postoperative pain management strategies. MATERIALS AND METHODS: A prospective cohort study performed at an academic medical center included a patient telephone questionnaire and chart review. Opioid prescriptions, opioid use, and patient reported outcomes were recorded. Bivariate analyses were used to compare patients who did and did not use opioids in the RARP cohort while overall trends were reported for the endourologic procedures. RESULTS: Of the 68 patients undergoing endoscopic intervention, 14 (21%) were prescribed an opioid and 6 (9%) reported any opioid use. 58 (85%) reported their pain was very well or well controlled while 9 reported their pain was poorly controlled. 59 (87%) were satisfied or very satisfied with their pain control. Fifty-three (93%) of the 57 patients undergoing RARP received an opioid prescription and only 23 reported any opioid use. All but 1 patient reported that their pain was well or very well controlled and almost all (54) of the patients were satisfied with their level of pain control. 36 (63%) reported their pain was less than expected while only 7 (12%) reported it was more than expected. CONCLUSION: Most patients undergoing endourologic procedures do not use postoperative opioids and report favorable outcomes regarding their pain control. Similarly, after RARP, most patients do not use opioids even when they are prescribed and are satisfied with their pain control.
引用
- An C, Jones E, Fujii MH, et al. Opioid Use and Associated Patient Satisfaction With Pain Control After Endoscopic Surgery and Robotic-Assisted Radical Prostatectomy. Urology. 2022. PMID: 36402273. doi:10.1016/j.urology.2022.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。